8 Oct

Moderna CAFC appeal could affect who gets covid vaccine revenues

The Federal Circuit yesterday heard oral arguments in IPR appeals initiated by Moderna Therapeutics. The outcome could either prevent or tee up a battle over the company’s covid-19 vaccine revenues.

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth